February 2025
1. CECCHINI M, Pilat MJ, Uboha N, Azad NS, et al
   Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.
   Cancer. 2025;131:e35755.
   

   >> Share

   
   
2. TAN S, Feng M, Zhou N, Zhang S, et al
   DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.
   Cancer. 2025;131:e35726.
   

   >> Share

   
   June 2024
3. SAJ F, Wu YL, Pant S, Goyal L, et al
   Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers.
   Cancer. 2024 Jun 14. doi: 10.1002/cncr.35352.
   

   >> Share

   
   
4. FONG ZV, Teinor J, Engineer L, Yeo TP, et al
   Caregiver-reported quality of communication in pancreatic and periampullary cancer.
   Cancer. 2024;130:2051-2059.
   

   >> Share

   
   March 2024
5. CHEUNG D, Stucky CC, Fong ZV
   The rise of biliary tract cancers and next-generation population registries.
   Cancer. 2024 Mar 19. doi: 10.1002/cncr.35284.
   

   >> Share

   
   February 2024
6. CHOI WJ, Roberts S, Verma A, Razak F, et al
   Characterizing the burden of biliary tract cancers across 28 hospitals in Ontario, Canada.
   Cancer. 2024 Feb 15. doi: 10.1002/cncr.35249.
   

   >> Share

   
   
7. PATEL SP, Guadarrama E, Chae YK, Dennis MJ, et al
   SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
   Cancer. 2024 Feb 15. doi: 10.1002/cncr.35243.
   

   >> Share

   
   July 2023
8. CAI QY, Yang P, Yang XL, Zhang XH, et al
   The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study.
   Cancer. 2023 Jul 14. doi: 10.1002/cncr.34854.
   

   >> Share

   
   May 2023
9. JANKU F, Javle MM, Sen S, Pant S, et al
   A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
   Cancer. 2023;129:1537-1546.
   

   >> Share

   
   March 2023
10. KEARNEY JF, Weighill D, Yeh JJ
    Promise of bile circulating tumor DNA in biliary tract cancers.
    Cancer. 2023 Mar 18. doi: 10.1002/cncr.34715.
    

    >> Share

    
    
11. OHYAMA H, Hirotsu Y, Amemiya K, Miura Y, et al
    Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile.
    Cancer. 2023 Mar 18. doi: 10.1002/cncr.34717.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share